as on October 18, 2025 at 1:29 am IST
Day's Low
Day's High
1.84%
Downside
0.94%
Upside
52 Week's Low
52 Week's High
25.41%
Downside
9.62%
Upside
Check Resmed Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$39.1B
EPS (TTM)
9.5009
Dividend Yield
0.81%
Quarterly Earnings Growth YOY
0.30%
PE Ratio (TTM)
28.16
Industry PE ratio
19.200384615384614
PEG Ratio
1.8635
EBITDA
1.9B
Revenue (TTM)
5.1B
Profit Margin
27.22%
Return On Equity TTM
25.86%
Track how Resmed Inc. P/E has moved over time to understand its valuation trends.
Resmed Inc. in the last 5 years
Lowest (22.59x)
December 31, 2023
Industry (19.20x)
October 20, 2025
Today (28.16x)
October 20, 2025
Highest (49.09x)
September 30, 2021
Today’s Price to Earnings Ratio: 28.16x
Compare market cap, revenue, PE, and other key metrics of Resmed Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $39.1B | 49.41% | 28.16 | 27.22% | |
BUY | $159.9B | 82.59% | 62.14 | 28.51% | |
BUY | $37.2B | 23.5% | 34.77 | 10.70% | |
BUY | $19.5B | -5.71% | 40.51 | 16.48% | |
BUY | $54.2B | -19.96% | 34.63 | 7.41% |
The Resmed Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Resmed Inc. investment value today
Current value as on today
₹1,16,469
Returns
₹16,469
(+16.47%)
Returns from Resmed Inc. Stock
₹11,675 (+11.67%)
Dollar Returns*
₹4,794 (+4.79%)
Based on 19 analysts
63.16%
Buy
36.84%
Hold
0.00%
Sell
Based on 19 analysts, 63.16% of analysts recommend a 'BUY' rating for Resmed Inc.. Average target price of $294.73
Get share price movements and forecasts by analysts on Resmed Inc..
What analysts predicted
9.06%UPSIDE
Target Price
$294.73
Current Price
$268.02
Analyzed by
19 Analysts
Target
$294.73
Resmed Inc. target price $294.73, a slight upside of 9.06% compared to current price of $268.02. According to 19 analysts rating.
Search interest for Resmed Inc. Stock has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 13 October
Mon, 03:17 PM
-ResMed launched Sleep Institute to enhance sleep health understanding, with a projected 7.8% revenue growth for 2025.
Mon, 04:07 PM
-ResMed reports strong constant currency growth and profitability, trading at $272.20 per share with a forward P/E of 25.2x.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Resmed Inc. has shown consistent revenue growth over the last 8 quarters. Revenue has increased from $1.10 billion to $1.34 billion, averaging a 2.8% increase each quarter.
Profit Spike
Resmed Inc. has shown consistent growth in its net profit over the last five quarters. The net profit increased from $292.23 million to $379.70 million, with an average rise of 6.3% each quarter.
Best in 1 Year
In the last 1 year, RMD has outperformed top 5 stocks with highest market-cap in its industry
Best in 3 Years
In the last 3 years, RMD has outperformed top 5 stocks with highest market-cap in its industry
Price Dip
In the last 7 days, RMD stock has moved down by -1.8%
Organisation | Resmed Inc. |
Headquarters | 9001 Spectrum Center Boulevard, San Diego, CA, United States, 92123 |
Industry | Health Technology |
CEO | Mr. Michael J. Farrell BE, MBA, SM |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Michael J. Farrell BE, MBA, SM | CEO & Chairman |
Mr. Justin Leong | Chief Product Officer |
Ms. Yvonne-Katrin Pucknat | Chief Marketing Officer |
Ms. Vered Keisar | Chief People Officer |
Ms. Sallilyn Schwartz | Chief Investor Relations Officer |
Mr. Jim Ellis | Chief Compliance Officer |
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD | Founder, Chair Emeritus & Non-Executive Director |
Mr. Brett A. Sandercock | Chief Financial Officer |
Mr. Michael J. Rider | Chief Legal Officer & Secretary |
Mr. Alastair Robertson | Chief Information Officer |
Resmed Inc. share price today is $268.02 as on at the close of the market. Resmed Inc. share today touched a day high of $270.54 and a low of $263.1.
Resmed Inc. share touched a 52 week high of $293.81 on and a 52 week low of $199.92 on . Resmed Inc. stock price today i.e. is closed at $268.02,which is 8.78% down from its 52 week high and 34.06% up from its 52 week low.
Resmed Inc. market capitalisation is $0.04T as on .
Indian investors can start investing in Resmed Inc. (RMD) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Resmed Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Resmed Inc. share’s latest price of $268.02 as on October 18, 2025 at 1:29 am IST, you will get 0.0373 shares of Resmed Inc.. Learn more about
fractional shares .
Resmed Inc. stock has given 49.41% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?